CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Health Insurance Coverage by Occupation Among Adults

Published: Mon, 18 Jun 2018 12:00:00 EDT
Are workers in certain occupations more likely to be uninsured? Did this change significantly after the ACA went into effect in 2014?
Morbidity & Mortality Weekly Report

Troponin-I Levels and Outcome in Patients With High CVD Risk

Published: Mon, 18 Jun 2018 12:00:00 EDT
Might troponin-I elevation serve as a prognostic marker for hospital mortality in critically ill patients with a high prevalence of cardiovascular risk factors?
BMC Anesthesiology

Pheochromocytoma/Paraganglioma and Cancer Metabolism

Published: Mon, 18 Jun 2018 12:00:00 EDT
A better understanding of the metabolic pathophysiology in pheochromocytomas/paragangliomas may lead to more targeted treatment for these tumors.
Journal of Clinical Endocrinology & Metabolism
Displaying results 10-12 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Apexigen, BMS to combine CD40 and anti-CSF-1 drugs with Opdivo in new study

Published: Thu, 14 Jun 2018 13:01:44 +0000
Apexigen is collaborating with Yale Cancer Center on an early-stage clinical trial that combines the biotech’s APX005M CD40 activator with Bristol-Myers Squibb’s Opdivo and cabiralizumab, an investigational anti-CSF-1 antibody, in patients with advanced solid tumors.

U.K. creates £2.5B investment program to help startups grow

Published: Thu, 14 Jun 2018 12:05:49 +0000
The U.K. has set up a £2.5 billion ($3.6 billion) patient capital program. The fund is part of an initiative to help British biotechs grow into standalone midsized businesses, rather than sell up at the first sign of a takeover bid from overseas.

Alta raises $130M for its new biotech VC fund, missing its $200M goal

Published: Wed, 13 Jun 2018 17:51:12 +0000
Healthcare venture capital firm Alta Partners has launched a new fund focused on companies developing new therapeutics and health technology services. It closed with $130 million, below the $200 million it had hoped to raise according to a February 2017 SEC filing.
Displaying results 10-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top